Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

2nd IFOM-IEO Campus Meeting on Cancer - New therapeutic anti-cancer strategies: shortening telomeres

08.05.2006


Without the enzyme that “regenerates” telomeres (the ends of DNA), stem cells lose functionality and the organism rapidly ages, while it acquires cancer resistance. The finding, which has significant implications in cancer and aging research, was presented yesterday at the 2nd IFOM-IEO Campus Meeting on Cancer (May 5th – 8th, IFOM-IEO Campus, Milan, Italy) by Marìa A. Blasco, of the Spanish National Cancer Center (CNIO) in Madrid (Spain).



Our cells’ DNA has a sort of “tail”: the telomeres. Every time our cells divide, telomeres get shorter and shorter. This progressive telomere shortening is compensated by the action of a specific enzyme, called “telomerase”, which is able to regenerate the tails; but in our cells there is not enough telomerase to keep telomeres at a constant length during our lifetime. And when telomeres get too short, cells stop replicating. Scientists have long hypothesized (and partially proved, with several experiments) that telomere shortening is correlated, on the one hand, to the general aging of the body (when many cells in a tissue stop replicating, the tissue becomes unable to regenerate itself and gets “old”) and, on the other hand, to cancer (tumour cells replicate much more than normal cells, therefore they need some mechanism to counteract natural telomere shortening).

To make the picture even more complicated, stem cells (the other big “stars” of modern biology research) might be the only cells that are able to produce the enzyme telomerase. Intuitively this makes sense, since stem cells are the “mother cells” of all cells, and they are necessary to the body to regenerate tissues and organs during lifetime. But, what is the role of telomerase in stem cells? And what could happen if the enzyme is absent? To answer these questions, Blasco and colleagues set up a series of experiments in mice. And they found that the lack of telomerase causes a severe defect in the fundamental functions of stem cells. “In particular – Blasco said – we have been looking at skin stem cells. And we observed that, in genetically modified mice that did not express telomerase, stem cells lost their functionality and became unable to regenerate the damaged epithelial tissue. On the whole, these mice aged more rapidly than normal mice. But, there was a very interesting side effect: without telomerase, mice showed a marked cancer resistance.” Further experiments on telomeres structure showed that every time the shortening process is altered, the result is either “early aging and cancer resistance” (if shortening is boosted), or “aging inhibition and more cancer occurrence” (if shortening is reduced).


“In our lab – Blasco added – we do basic research, but our results provide fundamental knowledge to those who work on the development of new therapeutic tools. In this very moment, preclinical trials are being carried out on drugs that are able to boost the action of telomerase. The potential anti-aging effect of these drugs might prove useful in the treatment of diseases such as AIDS, where tissues age rapidly. In tumours, it is necessary to implement the opposite strategy: there are drugs, now in clinical trials, that inhibit telomerase action and increase telomeres shortening.” In the light of the new finding, such therapy might prove to be effective against cancer stem cells, that today are considered the most “malignant” culprit of cancer.

Francesca Noceti | alfa
Further information:
http://www.ifom-ieo-campus.it
http://www.semm.it/meeting/cancer06/

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>